SlideShare a Scribd company logo
MICROBIAL PRODUCTION OF
CHEMOTHERAPEUTIC AGENTS
 Antibiotic
Antibiotic as originally defined was a chemical
substance produced by various species of
microorganisms that was capable of inhibiting the
growth or kill the microorganism.
 Antimicrobial Agents
Antimicrobial agents is a chemical substance which
inhibit or kill the microorganism.
Introduction
 Antibiotics are a special category of chemotherapeutic
agents that are administered to fight infections, usually
microbial, of humans and animals.
 the classical definition of antibiotics associates it with
secondary metabolite, the term antibiotic today
includes many similar but chemically synthesized
chemotherapeutic compounds also.
 Over 8000 antibiotics are known and several hundreds
discovered yearly.
 Nearly 3000 antibiotically active substances have been
detected in lichens, algae, higher animals and plants.
 Each year about 300 new antibiotically active
substances are detected of which 30-35% are
secondary components from fermentation with
known antibiotics.
 only 123 are currently being produced by
fermentation. In addition, some 50 antibiotics are
produced as semisynthetic antibiotics.
 Three antibiotics, viz., phosphonomycin,
pyrrolnitrin and chloramphenicol are produced
completely synthetically.
Examples of organisms capable of
producing antibiotics
Ideal Characteristics of
antibiotic
 Wide spectrum: it must be active against a
wide range of pathogens
 Prevent the development of resistant forms:
pathogens should not easily gain resistance
to the antibiotic in question
 Selective nature: it must act only against the
target and not the host organism
 Not disturb the normal gut flora when orally
administered
Classification of Antibiotic
STREPTOMYCIN
 Streptomycin is an aminoglycoside antibiotic
produced by selected strains of Streptomyces
griseus.
 The antibiotic works by inhibiting the
synthesis of DNA and proteins.
CHEMISTRY
 It is basic in nature, with solubility in water at the rate
of 20 g/L.
 It is stable to pH changes.
 It can withstand boiling temperature.
 Being a base, streptomycin is usually produced as
salt, normally of HCl and sulfate.
 One unit of streptomycin is equal to 1 μg of free base.
 Streptomycin is composed of 3 subunits: (i)
aminocyclitol (= streptidine), (ii) L-streptose, and (iii)
Nmethyl- L-glucosamine.
Some streptomycins and their R
groups
USES
 In the treatment of tuberculosis, urinary tract
infection, systemic infection by Gram positive
bacteria
 for bacteria that have gained resistance to
penicillin.
 Non-medical uses include preparation of
selective media
 in cloning experiments
 as laboratory standard for quantitative
analysis of streptomycin.
LIMITATIONS
 The antibiotic exerts a neurotoxic reaction upon
prolonged use.
 It can lead to hearing loss and loss of balance (that
is, it is ototoxic).
 Streptomycin may sometimes damage kidney also.
 The drug may lead to development of
streptomycin-resistant forms. It is therefore
advisable to use the drug along with p-
aminosalicylic acid or isoniazid.
 Dihydrostreptomycin has lesser side effects than
streptomycin.
MODE OF ACTION
 It affect protein synthesis, the target of this
antibiotic is the 30S subunit of the 70S ribosome
of the prokaryotes.
 It strongly inhibits initiation and elongation of
peptide chains.
 It also causes misreading of mRNA thereby
leading to insertion of wrong amino acids
 Finally, under the influence of streptomycin,
some molecules of nucleic acids (e.g., rRNA,
tRNA, and denatured DNA) also act as mRNA
although they ordinarily do not have this
property.
BIOSYNTHESIS OF STREPTOMYCIN
 It follows three pathway.
 Glucose act as sole source of carbon.
 It involves 28 enzymes.
 The final intermediate of the pathway,
streptomycin phosphate, is biologically inactive but
becomes active following removal of the
phosphate group.
 Many organisms synthesize
mannosidostreptomycin before the actual
formation of streptomycin.
 mannosidostreptomycin is degraded by the
organism’
s own enzyme
mannosidostreptomycinase to yield streptomycin.
 In fermentation, the concentration of
mannosidostreptomycin can reach up to 40%.
 Biosynthesis of streptomycin is regulated by an
inducer called FactorA.
 The antibiotic is synthesized in the idiophase and
this occurs only after factorA has reached a critical
concentration.
GENERAL PRODUCTION METHOD
a. MICROBIAL STRAIN
 Streptomyces griseus is used for production of
streptomycin
 Walksman’
s discovered the species and till now it
has been using
 The productivity of Streptomyces griseus has
increased by over 100 fold.
 Classical mutation programs are used for the
improvement of the strain
b. CULTURE MEDIUM
 Glucose is the carbon source of choice, because it is precursor
for streptomycin.
 The preferred nitrogen source is soybean flour meal.
 Minerals are automatically inclusive because of the complex
nature of the medium.
PRODUCTION
 The inoculum is built up in a stepwise manner at 27°C.
 The process starts with the plate culturing of
lyophilized spore cultures in soy flour agar medium.
 Incubation is done at 27°C for 2-3 weeks.
 The spores are then transferred to shaker flask.
 After growth for some time the whole is again
transferred to propagator for biomass build up.
 The medium is sterilized as usual.
 The fermenter is inoculated at the rate of 5-10%
vol/vol.The process is aerobic.
 Inadequate supply of air (O2) leads to accumulation of
lactate and pyruvate, which is undesirable.
 The pH is maintained at around 7 and fermentation carried
out at 27°C.
 The fermentation is triphasic.Trophophase lasts for 24 hrs.
 The pH increases preferential utilization of soybean meal.
 Growth and concomitant accumulation of Factor A also
rapid.
 Idiophase lasts for 2-7 days during which streptomycin is
rapidly synthesized.Glucose utilization is very rapid.
 The third phase marks the cessation of antibiotic synthesis.
 Cells begin to lyse, and pH rises due to NH3 liberation.
 Harvesting is done before the third phase commences.
 The yield is about 1200 μg/ml.
RECOVERY
 The broth (beer) is filtered in rotary vacuum filter to
remove mycelia.
 Water is added to the liquor in the ratio 1:1 and passed
through adsorption column.
 Through the same column, EDTA solution is passed to
remove metal ions.
 The adsorbed, pure streptomycin is eluted from the
column with 2.5 N H2SO4.
 Further processing entails decolorizing with carbon,
antigen removal by filtration, concentration, and
drying.
 The final product is either sulfate- or hydrochloride salt
of streptomycin.
 The purity will be of the order of 98%.
TETRACYCLINE
Introduction
 Tetracyclines are a group of broad-spectrum antibiotics
 They can be prepared microbiologically as well as
chemically
 Tetracycline has low toxicity and good oral absorption.
 It is bacteriostatic and requires high dosage.
 Examples ofTetracycline and organism
Structure of Tetracycline
Uses
 This antibiotic is used in the treatment of
shigellosis, salmonellosis, typhoid fever,
brucellosis, etc.
 It is also used in feed to eliminate parasites (and
thus help weight gain in animals).
 The antibiotic also finds use in the preservation of
fish (the ice in which the fish is kept is treated with
tetracycline).
PRODUCTION OF TETRACYCLINE
 Tetracycline can be produced chemically as well as
microbiologically.
 The microbial production of all tetracyclines is
similar.
 Chlortetracycline production, however, is
comparatively simpler than the production of
other tetracyclines.
 In particular, production of tetracycline is very
sensitive to chloride content in the medium: it
leads to the production of chlortetracycline rather
than the tetracycline
FERMENTATION
 For trade fermentations, UV mutants of
Streptomyces aureofaciens are used.
 The organism comes in the form of lyophilized
spores.
 The inoculum preparation requires several stages.
 Starting from the spores dried on sand or lyophil
vials, one or more shake flask stages may be used
and then one or two inoculum tank stages.
 The sporulation medium, inoculum build-up
medium and the production medium have different
compositions
 During inoculum build-up, the organism remains in the
shake-flask for 24 hours at 28°C.
 The final propagator uses medium of the same
composition.
 About 5% inoculum is added and propagation carried
out for 19-24 hours at pH 5.2-6.2.
 The main fermenter receives 2-10% of inoculum from
the final propagator.
 The fermenter has a nominal capacity of 5000 to 15000
gallons.
 Fermentation is carried out in sterilized medium (121°C
for 12 hour).
 The main fermentation runs for 60-65 hours at 28°C.
 The pH is around 5.8-6.
 It is a submerged fermentation requiring 0.5-2
vol/vol/min of aeration.
 Agitation is carried out with mechanical agitators.
 Lard is used as antifoam.
 Glucose is generally not used in the main
fermentation as this exerts catabolite repression.
 The yield is around 15000 units per ml.
HARVESTING AND PURIFICATION

More Related Content

Similar to antibiotiiiiiiiiiiiiiiiiiiiiiiiiiic.pptx

3,Antibiotics that inhibit bacterial protein synthesis.ppt
3,Antibiotics that inhibit bacterial protein synthesis.ppt3,Antibiotics that inhibit bacterial protein synthesis.ppt
3,Antibiotics that inhibit bacterial protein synthesis.ppt
ssusera7496f
 
Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...
Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...
Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...
bidyarajghosh
 
Microbial growth stages
Microbial growth stagesMicrobial growth stages
Microbial growth stages
Ahmed Abdellatif
 
Penicillin production by Likhith K
Penicillin production by Likhith KPenicillin production by Likhith K
Penicillin production by Likhith K
LIKHITHK1
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Surender Rawat
 
2 fermentation penicillin.pptx pharmacognosy
2 fermentation penicillin.pptx pharmacognosy2 fermentation penicillin.pptx pharmacognosy
2 fermentation penicillin.pptx pharmacognosy
IdenyiDanielEwaEde
 
Large scale production of antibiotics.pptx
Large scale production of antibiotics.pptxLarge scale production of antibiotics.pptx
Large scale production of antibiotics.pptx
AkhilS634645
 
Fermentation technology
Fermentation technologyFermentation technology
Fermentation technology
Amrita Sutradhar
 
Production of tetracyclin and cephalosporin
Production of tetracyclin and cephalosporinProduction of tetracyclin and cephalosporin
Production of tetracyclin and cephalosporin
SamsuDeen12
 
Chapter 6 Application of microbes in medical biotechnology.pptx
Chapter  6 Application of microbes in medical biotechnology.pptxChapter  6 Application of microbes in medical biotechnology.pptx
Chapter 6 Application of microbes in medical biotechnology.pptx
AsmamawTesfaw1
 
Streptomycin
StreptomycinStreptomycin
Streptomycin
Mohit Kohli
 
industrial microbiology.pptx
industrial microbiology.pptxindustrial microbiology.pptx
industrial microbiology.pptx
KasthurikeerthanaTam
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)
Dr. Ravi Sankar
 
Pharmaceutical note on antibiotics Erythromycin.pptx
Pharmaceutical note on antibiotics Erythromycin.pptxPharmaceutical note on antibiotics Erythromycin.pptx
Pharmaceutical note on antibiotics Erythromycin.pptx
IdenyiDanielEwaEde
 
Industrial microbiology presentation ppt
Industrial microbiology presentation pptIndustrial microbiology presentation ppt
Industrial microbiology presentation ppt
Gedefawwubie
 
Scope of biotechnology
Scope of  biotechnologyScope of  biotechnology
Scope of biotechnologykhehkesha
 
Streptomycin- Pharmaceutical Microbiology
Streptomycin-  Pharmaceutical MicrobiologyStreptomycin-  Pharmaceutical Microbiology
Streptomycin- Pharmaceutical Microbiology
Sanchit Dhankhar
 
Streptomycin
StreptomycinStreptomycin
Streptomycin
Mohammad Ahmed Khan
 
Anti infective agents
Anti infective agentsAnti infective agents
Anti infective agents
Khaled Shurrab
 

Similar to antibiotiiiiiiiiiiiiiiiiiiiiiiiiiic.pptx (20)

3,Antibiotics that inhibit bacterial protein synthesis.ppt
3,Antibiotics that inhibit bacterial protein synthesis.ppt3,Antibiotics that inhibit bacterial protein synthesis.ppt
3,Antibiotics that inhibit bacterial protein synthesis.ppt
 
Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...
Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...
Presentation on antibiotics (specially nisin) by bidyaraj ghosh and sudipta m...
 
Microbial growth stages
Microbial growth stagesMicrobial growth stages
Microbial growth stages
 
Penicillin production by Likhith K
Penicillin production by Likhith KPenicillin production by Likhith K
Penicillin production by Likhith K
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
2 fermentation penicillin.pptx pharmacognosy
2 fermentation penicillin.pptx pharmacognosy2 fermentation penicillin.pptx pharmacognosy
2 fermentation penicillin.pptx pharmacognosy
 
Large scale production of antibiotics.pptx
Large scale production of antibiotics.pptxLarge scale production of antibiotics.pptx
Large scale production of antibiotics.pptx
 
Fermentation technology
Fermentation technologyFermentation technology
Fermentation technology
 
Production of tetracyclin and cephalosporin
Production of tetracyclin and cephalosporinProduction of tetracyclin and cephalosporin
Production of tetracyclin and cephalosporin
 
Chapter 6 Application of microbes in medical biotechnology.pptx
Chapter  6 Application of microbes in medical biotechnology.pptxChapter  6 Application of microbes in medical biotechnology.pptx
Chapter 6 Application of microbes in medical biotechnology.pptx
 
Streptomycin
StreptomycinStreptomycin
Streptomycin
 
industrial microbiology.pptx
industrial microbiology.pptxindustrial microbiology.pptx
industrial microbiology.pptx
 
Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)Aminoglycosides(medicinal chemistry by p.ravisankar)
Aminoglycosides(medicinal chemistry by p.ravisankar)
 
Pharmaceutical note on antibiotics Erythromycin.pptx
Pharmaceutical note on antibiotics Erythromycin.pptxPharmaceutical note on antibiotics Erythromycin.pptx
Pharmaceutical note on antibiotics Erythromycin.pptx
 
Industrial microbiology presentation ppt
Industrial microbiology presentation pptIndustrial microbiology presentation ppt
Industrial microbiology presentation ppt
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Scope of biotechnology
Scope of  biotechnologyScope of  biotechnology
Scope of biotechnology
 
Streptomycin- Pharmaceutical Microbiology
Streptomycin-  Pharmaceutical MicrobiologyStreptomycin-  Pharmaceutical Microbiology
Streptomycin- Pharmaceutical Microbiology
 
Streptomycin
StreptomycinStreptomycin
Streptomycin
 
Anti infective agents
Anti infective agentsAnti infective agents
Anti infective agents
 

More from DiptiPriya6

meningitis-20000000000729103712 (1).pptx
meningitis-20000000000729103712 (1).pptxmeningitis-20000000000729103712 (1).pptx
meningitis-20000000000729103712 (1).pptx
DiptiPriya6
 
communiccccccccccccccccablediseases.pptx
communiccccccccccccccccablediseases.pptxcommuniccccccccccccccccablediseases.pptx
communiccccccccccccccccablediseases.pptx
DiptiPriya6
 
Tuberculosis (tttttTB) Presentation.pptx
Tuberculosis (tttttTB) Presentation.pptxTuberculosis (tttttTB) Presentation.pptx
Tuberculosis (tttttTB) Presentation.pptx
DiptiPriya6
 
15-1511182123277777777-lva1-app6892.pptx
15-1511182123277777777-lva1-app6892.pptx15-1511182123277777777-lva1-app6892.pptx
15-1511182123277777777-lva1-app6892.pptx
DiptiPriya6
 
Lecture 6- Bacteria- Pathathogenesis.ppt
Lecture 6- Bacteria- Pathathogenesis.pptLecture 6- Bacteria- Pathathogenesis.ppt
Lecture 6- Bacteria- Pathathogenesis.ppt
DiptiPriya6
 
thesis of copper nanoparticles and their relevance
thesis of copper nanoparticles and their relevancethesis of copper nanoparticles and their relevance
thesis of copper nanoparticles and their relevance
DiptiPriya6
 
Newer_Antibioticcccccccccccccccccccs.ppt
Newer_Antibioticcccccccccccccccccccs.pptNewer_Antibioticcccccccccccccccccccs.ppt
Newer_Antibioticcccccccccccccccccccs.ppt
DiptiPriya6
 
azollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptx
azollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptxazollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptx
azollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptx
DiptiPriya6
 
mmmmmmmmmmmmmmmmMicrobial fuel cell.pptx
mmmmmmmmmmmmmmmmMicrobial fuel cell.pptxmmmmmmmmmmmmmmmmMicrobial fuel cell.pptx
mmmmmmmmmmmmmmmmMicrobial fuel cell.pptx
DiptiPriya6
 
RTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
RTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxRTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
RTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
DiptiPriya6
 
presentation llipase enzyme from(1).pptx
presentation llipase enzyme from(1).pptxpresentation llipase enzyme from(1).pptx
presentation llipase enzyme from(1).pptx
DiptiPriya6
 
10- Funnnnngi and Their Pathogenesis.ppt
10- Funnnnngi and Their Pathogenesis.ppt10- Funnnnngi and Their Pathogenesis.ppt
10- Funnnnngi and Their Pathogenesis.ppt
DiptiPriya6
 
bbbbbbbbBiosynthesis of amino acids.pptx
bbbbbbbbBiosynthesis of amino acids.pptxbbbbbbbbBiosynthesis of amino acids.pptx
bbbbbbbbBiosynthesis of amino acids.pptx
DiptiPriya6
 
cyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptx
cyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptxcyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptx
cyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptx
DiptiPriya6
 
MFffffffffffffffffffffffffffffffffC.pptx
MFffffffffffffffffffffffffffffffffC.pptxMFffffffffffffffffffffffffffffffffC.pptx
MFffffffffffffffffffffffffffffffffC.pptx
DiptiPriya6
 
huuuuuuuuuuuuuuuuumanmicrobialflora.pptx
huuuuuuuuuuuuuuuuumanmicrobialflora.pptxhuuuuuuuuuuuuuuuuumanmicrobialflora.pptx
huuuuuuuuuuuuuuuuumanmicrobialflora.pptx
DiptiPriya6
 
microbialflavouuuuuurs-200605130258.pptx
microbialflavouuuuuurs-200605130258.pptxmicrobialflavouuuuuurs-200605130258.pptx
microbialflavouuuuuurs-200605130258.pptx
DiptiPriya6
 
Bacterial nutrTTTTTTTTTTTTTTTTition.pptx
Bacterial nutrTTTTTTTTTTTTTTTTition.pptxBacterial nutrTTTTTTTTTTTTTTTTition.pptx
Bacterial nutrTTTTTTTTTTTTTTTTition.pptx
DiptiPriya6
 
2 3butanidiol path wayy fermetation.pptx
2 3butanidiol path wayy fermetation.pptx2 3butanidiol path wayy fermetation.pptx
2 3butanidiol path wayy fermetation.pptx
DiptiPriya6
 
cyanobacteriapptrecent-210706173707.pptx
cyanobacteriapptrecent-210706173707.pptxcyanobacteriapptrecent-210706173707.pptx
cyanobacteriapptrecent-210706173707.pptx
DiptiPriya6
 

More from DiptiPriya6 (20)

meningitis-20000000000729103712 (1).pptx
meningitis-20000000000729103712 (1).pptxmeningitis-20000000000729103712 (1).pptx
meningitis-20000000000729103712 (1).pptx
 
communiccccccccccccccccablediseases.pptx
communiccccccccccccccccablediseases.pptxcommuniccccccccccccccccablediseases.pptx
communiccccccccccccccccablediseases.pptx
 
Tuberculosis (tttttTB) Presentation.pptx
Tuberculosis (tttttTB) Presentation.pptxTuberculosis (tttttTB) Presentation.pptx
Tuberculosis (tttttTB) Presentation.pptx
 
15-1511182123277777777-lva1-app6892.pptx
15-1511182123277777777-lva1-app6892.pptx15-1511182123277777777-lva1-app6892.pptx
15-1511182123277777777-lva1-app6892.pptx
 
Lecture 6- Bacteria- Pathathogenesis.ppt
Lecture 6- Bacteria- Pathathogenesis.pptLecture 6- Bacteria- Pathathogenesis.ppt
Lecture 6- Bacteria- Pathathogenesis.ppt
 
thesis of copper nanoparticles and their relevance
thesis of copper nanoparticles and their relevancethesis of copper nanoparticles and their relevance
thesis of copper nanoparticles and their relevance
 
Newer_Antibioticcccccccccccccccccccs.ppt
Newer_Antibioticcccccccccccccccccccs.pptNewer_Antibioticcccccccccccccccccccs.ppt
Newer_Antibioticcccccccccccccccccccs.ppt
 
azollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptx
azollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptxazollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptx
azollaaaaaaaaaaaaaaaaaaaaaaaaaaappt.pptx
 
mmmmmmmmmmmmmmmmMicrobial fuel cell.pptx
mmmmmmmmmmmmmmmmMicrobial fuel cell.pptxmmmmmmmmmmmmmmmmMicrobial fuel cell.pptx
mmmmmmmmmmmmmmmmMicrobial fuel cell.pptx
 
RTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
RTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxRTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
RTI.pptxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
 
presentation llipase enzyme from(1).pptx
presentation llipase enzyme from(1).pptxpresentation llipase enzyme from(1).pptx
presentation llipase enzyme from(1).pptx
 
10- Funnnnngi and Their Pathogenesis.ppt
10- Funnnnngi and Their Pathogenesis.ppt10- Funnnnngi and Their Pathogenesis.ppt
10- Funnnnngi and Their Pathogenesis.ppt
 
bbbbbbbbBiosynthesis of amino acids.pptx
bbbbbbbbBiosynthesis of amino acids.pptxbbbbbbbbBiosynthesis of amino acids.pptx
bbbbbbbbBiosynthesis of amino acids.pptx
 
cyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptx
cyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptxcyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptx
cyano bacteriaaaaaaaaaaaaaaaaaaa(1).pptx
 
MFffffffffffffffffffffffffffffffffC.pptx
MFffffffffffffffffffffffffffffffffC.pptxMFffffffffffffffffffffffffffffffffC.pptx
MFffffffffffffffffffffffffffffffffC.pptx
 
huuuuuuuuuuuuuuuuumanmicrobialflora.pptx
huuuuuuuuuuuuuuuuumanmicrobialflora.pptxhuuuuuuuuuuuuuuuuumanmicrobialflora.pptx
huuuuuuuuuuuuuuuuumanmicrobialflora.pptx
 
microbialflavouuuuuurs-200605130258.pptx
microbialflavouuuuuurs-200605130258.pptxmicrobialflavouuuuuurs-200605130258.pptx
microbialflavouuuuuurs-200605130258.pptx
 
Bacterial nutrTTTTTTTTTTTTTTTTition.pptx
Bacterial nutrTTTTTTTTTTTTTTTTition.pptxBacterial nutrTTTTTTTTTTTTTTTTition.pptx
Bacterial nutrTTTTTTTTTTTTTTTTition.pptx
 
2 3butanidiol path wayy fermetation.pptx
2 3butanidiol path wayy fermetation.pptx2 3butanidiol path wayy fermetation.pptx
2 3butanidiol path wayy fermetation.pptx
 
cyanobacteriapptrecent-210706173707.pptx
cyanobacteriapptrecent-210706173707.pptxcyanobacteriapptrecent-210706173707.pptx
cyanobacteriapptrecent-210706173707.pptx
 

Recently uploaded

"Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for...
"Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for..."Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for...
"Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for...
MMariSelvam4
 
AGRICULTURE Hydrophonic FERTILISER PPT.pptx
AGRICULTURE Hydrophonic FERTILISER PPT.pptxAGRICULTURE Hydrophonic FERTILISER PPT.pptx
AGRICULTURE Hydrophonic FERTILISER PPT.pptx
BanitaDsouza
 
Alert-driven Community-based Forest monitoring: A case of the Peruvian Amazon
Alert-driven Community-based Forest monitoring: A case of the Peruvian AmazonAlert-driven Community-based Forest monitoring: A case of the Peruvian Amazon
Alert-driven Community-based Forest monitoring: A case of the Peruvian Amazon
CIFOR-ICRAF
 
Summary of the Climate and Energy Policy of Australia
Summary of the Climate and Energy Policy of AustraliaSummary of the Climate and Energy Policy of Australia
Summary of the Climate and Energy Policy of Australia
yasmindemoraes1
 
Navigating the complex landscape of AI governance
Navigating the complex landscape of AI governanceNavigating the complex landscape of AI governance
Navigating the complex landscape of AI governance
Piermenotti Mauro
 
Characterization and the Kinetics of drying at the drying oven and with micro...
Characterization and the Kinetics of drying at the drying oven and with micro...Characterization and the Kinetics of drying at the drying oven and with micro...
Characterization and the Kinetics of drying at the drying oven and with micro...
Open Access Research Paper
 
Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...
Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...
Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...
Open Access Research Paper
 
ppt on beauty of the nature by Palak.pptx
ppt on  beauty of the nature by Palak.pptxppt on  beauty of the nature by Palak.pptx
ppt on beauty of the nature by Palak.pptx
RaniJaiswal16
 
IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...
IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...
IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...
ipcc-media
 
Artificial Reefs by Kuddle Life Foundation - May 2024
Artificial Reefs by Kuddle Life Foundation - May 2024Artificial Reefs by Kuddle Life Foundation - May 2024
Artificial Reefs by Kuddle Life Foundation - May 2024
punit537210
 
UNDERSTANDING WHAT GREEN WASHING IS!.pdf
UNDERSTANDING WHAT GREEN WASHING IS!.pdfUNDERSTANDING WHAT GREEN WASHING IS!.pdf
UNDERSTANDING WHAT GREEN WASHING IS!.pdf
JulietMogola
 
NRW Board Paper - DRAFT NRW Recreation Strategy
NRW Board Paper - DRAFT NRW Recreation StrategyNRW Board Paper - DRAFT NRW Recreation Strategy
NRW Board Paper - DRAFT NRW Recreation Strategy
Robin Grant
 
DRAFT NRW Recreation Strategy - People and Nature thriving together
DRAFT NRW Recreation Strategy - People and Nature thriving togetherDRAFT NRW Recreation Strategy - People and Nature thriving together
DRAFT NRW Recreation Strategy - People and Nature thriving together
Robin Grant
 
growbilliontrees.com-Trees for Granddaughter (1).pdf
growbilliontrees.com-Trees for Granddaughter (1).pdfgrowbilliontrees.com-Trees for Granddaughter (1).pdf
growbilliontrees.com-Trees for Granddaughter (1).pdf
yadavakashagra
 
Natural farming @ Dr. Siddhartha S. Jena.pptx
Natural farming @ Dr. Siddhartha S. Jena.pptxNatural farming @ Dr. Siddhartha S. Jena.pptx
Natural farming @ Dr. Siddhartha S. Jena.pptx
sidjena70
 
Sustainable farming practices in India .pptx
Sustainable farming  practices in India .pptxSustainable farming  practices in India .pptx
Sustainable farming practices in India .pptx
chaitaliambole
 
Environmental Science Book By Dr. Y.K. Singh
Environmental Science Book By Dr. Y.K. SinghEnvironmental Science Book By Dr. Y.K. Singh
Environmental Science Book By Dr. Y.K. Singh
AhmadKhan917612
 
International+e-Commerce+Platform-www.cfye-commerce.shop
International+e-Commerce+Platform-www.cfye-commerce.shopInternational+e-Commerce+Platform-www.cfye-commerce.shop
International+e-Commerce+Platform-www.cfye-commerce.shop
laozhuseo02
 
Prevalence, biochemical and hematological study of diabetic patients
Prevalence, biochemical and hematological study of diabetic patientsPrevalence, biochemical and hematological study of diabetic patients
Prevalence, biochemical and hematological study of diabetic patients
Open Access Research Paper
 
Bhopal Gas Leak Tragedy - A Night of death
Bhopal Gas Leak Tragedy - A Night of deathBhopal Gas Leak Tragedy - A Night of death
Bhopal Gas Leak Tragedy - A Night of death
upasana742003
 

Recently uploaded (20)

"Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for...
"Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for..."Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for...
"Understanding the Carbon Cycle: Processes, Human Impacts, and Strategies for...
 
AGRICULTURE Hydrophonic FERTILISER PPT.pptx
AGRICULTURE Hydrophonic FERTILISER PPT.pptxAGRICULTURE Hydrophonic FERTILISER PPT.pptx
AGRICULTURE Hydrophonic FERTILISER PPT.pptx
 
Alert-driven Community-based Forest monitoring: A case of the Peruvian Amazon
Alert-driven Community-based Forest monitoring: A case of the Peruvian AmazonAlert-driven Community-based Forest monitoring: A case of the Peruvian Amazon
Alert-driven Community-based Forest monitoring: A case of the Peruvian Amazon
 
Summary of the Climate and Energy Policy of Australia
Summary of the Climate and Energy Policy of AustraliaSummary of the Climate and Energy Policy of Australia
Summary of the Climate and Energy Policy of Australia
 
Navigating the complex landscape of AI governance
Navigating the complex landscape of AI governanceNavigating the complex landscape of AI governance
Navigating the complex landscape of AI governance
 
Characterization and the Kinetics of drying at the drying oven and with micro...
Characterization and the Kinetics of drying at the drying oven and with micro...Characterization and the Kinetics of drying at the drying oven and with micro...
Characterization and the Kinetics of drying at the drying oven and with micro...
 
Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...
Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...
Micro RNA genes and their likely influence in rice (Oryza sativa L.) dynamic ...
 
ppt on beauty of the nature by Palak.pptx
ppt on  beauty of the nature by Palak.pptxppt on  beauty of the nature by Palak.pptx
ppt on beauty of the nature by Palak.pptx
 
IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...
IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...
IPCC Vice Chair Ladislaus Change Central Asia Climate Change Conference 27 Ma...
 
Artificial Reefs by Kuddle Life Foundation - May 2024
Artificial Reefs by Kuddle Life Foundation - May 2024Artificial Reefs by Kuddle Life Foundation - May 2024
Artificial Reefs by Kuddle Life Foundation - May 2024
 
UNDERSTANDING WHAT GREEN WASHING IS!.pdf
UNDERSTANDING WHAT GREEN WASHING IS!.pdfUNDERSTANDING WHAT GREEN WASHING IS!.pdf
UNDERSTANDING WHAT GREEN WASHING IS!.pdf
 
NRW Board Paper - DRAFT NRW Recreation Strategy
NRW Board Paper - DRAFT NRW Recreation StrategyNRW Board Paper - DRAFT NRW Recreation Strategy
NRW Board Paper - DRAFT NRW Recreation Strategy
 
DRAFT NRW Recreation Strategy - People and Nature thriving together
DRAFT NRW Recreation Strategy - People and Nature thriving togetherDRAFT NRW Recreation Strategy - People and Nature thriving together
DRAFT NRW Recreation Strategy - People and Nature thriving together
 
growbilliontrees.com-Trees for Granddaughter (1).pdf
growbilliontrees.com-Trees for Granddaughter (1).pdfgrowbilliontrees.com-Trees for Granddaughter (1).pdf
growbilliontrees.com-Trees for Granddaughter (1).pdf
 
Natural farming @ Dr. Siddhartha S. Jena.pptx
Natural farming @ Dr. Siddhartha S. Jena.pptxNatural farming @ Dr. Siddhartha S. Jena.pptx
Natural farming @ Dr. Siddhartha S. Jena.pptx
 
Sustainable farming practices in India .pptx
Sustainable farming  practices in India .pptxSustainable farming  practices in India .pptx
Sustainable farming practices in India .pptx
 
Environmental Science Book By Dr. Y.K. Singh
Environmental Science Book By Dr. Y.K. SinghEnvironmental Science Book By Dr. Y.K. Singh
Environmental Science Book By Dr. Y.K. Singh
 
International+e-Commerce+Platform-www.cfye-commerce.shop
International+e-Commerce+Platform-www.cfye-commerce.shopInternational+e-Commerce+Platform-www.cfye-commerce.shop
International+e-Commerce+Platform-www.cfye-commerce.shop
 
Prevalence, biochemical and hematological study of diabetic patients
Prevalence, biochemical and hematological study of diabetic patientsPrevalence, biochemical and hematological study of diabetic patients
Prevalence, biochemical and hematological study of diabetic patients
 
Bhopal Gas Leak Tragedy - A Night of death
Bhopal Gas Leak Tragedy - A Night of deathBhopal Gas Leak Tragedy - A Night of death
Bhopal Gas Leak Tragedy - A Night of death
 

antibiotiiiiiiiiiiiiiiiiiiiiiiiiiic.pptx

  • 2.  Antibiotic Antibiotic as originally defined was a chemical substance produced by various species of microorganisms that was capable of inhibiting the growth or kill the microorganism.  Antimicrobial Agents Antimicrobial agents is a chemical substance which inhibit or kill the microorganism.
  • 3. Introduction  Antibiotics are a special category of chemotherapeutic agents that are administered to fight infections, usually microbial, of humans and animals.  the classical definition of antibiotics associates it with secondary metabolite, the term antibiotic today includes many similar but chemically synthesized chemotherapeutic compounds also.  Over 8000 antibiotics are known and several hundreds discovered yearly.  Nearly 3000 antibiotically active substances have been detected in lichens, algae, higher animals and plants.
  • 4.  Each year about 300 new antibiotically active substances are detected of which 30-35% are secondary components from fermentation with known antibiotics.  only 123 are currently being produced by fermentation. In addition, some 50 antibiotics are produced as semisynthetic antibiotics.  Three antibiotics, viz., phosphonomycin, pyrrolnitrin and chloramphenicol are produced completely synthetically.
  • 5. Examples of organisms capable of producing antibiotics
  • 6. Ideal Characteristics of antibiotic  Wide spectrum: it must be active against a wide range of pathogens  Prevent the development of resistant forms: pathogens should not easily gain resistance to the antibiotic in question  Selective nature: it must act only against the target and not the host organism  Not disturb the normal gut flora when orally administered
  • 8.
  • 9.
  • 10. STREPTOMYCIN  Streptomycin is an aminoglycoside antibiotic produced by selected strains of Streptomyces griseus.  The antibiotic works by inhibiting the synthesis of DNA and proteins.
  • 11. CHEMISTRY  It is basic in nature, with solubility in water at the rate of 20 g/L.  It is stable to pH changes.  It can withstand boiling temperature.  Being a base, streptomycin is usually produced as salt, normally of HCl and sulfate.  One unit of streptomycin is equal to 1 μg of free base.  Streptomycin is composed of 3 subunits: (i) aminocyclitol (= streptidine), (ii) L-streptose, and (iii) Nmethyl- L-glucosamine.
  • 12.
  • 13. Some streptomycins and their R groups
  • 14. USES  In the treatment of tuberculosis, urinary tract infection, systemic infection by Gram positive bacteria  for bacteria that have gained resistance to penicillin.  Non-medical uses include preparation of selective media  in cloning experiments  as laboratory standard for quantitative analysis of streptomycin.
  • 15. LIMITATIONS  The antibiotic exerts a neurotoxic reaction upon prolonged use.  It can lead to hearing loss and loss of balance (that is, it is ototoxic).  Streptomycin may sometimes damage kidney also.  The drug may lead to development of streptomycin-resistant forms. It is therefore advisable to use the drug along with p- aminosalicylic acid or isoniazid.  Dihydrostreptomycin has lesser side effects than streptomycin.
  • 16. MODE OF ACTION  It affect protein synthesis, the target of this antibiotic is the 30S subunit of the 70S ribosome of the prokaryotes.  It strongly inhibits initiation and elongation of peptide chains.  It also causes misreading of mRNA thereby leading to insertion of wrong amino acids  Finally, under the influence of streptomycin, some molecules of nucleic acids (e.g., rRNA, tRNA, and denatured DNA) also act as mRNA although they ordinarily do not have this property.
  • 17.
  • 18. BIOSYNTHESIS OF STREPTOMYCIN  It follows three pathway.  Glucose act as sole source of carbon.  It involves 28 enzymes.  The final intermediate of the pathway, streptomycin phosphate, is biologically inactive but becomes active following removal of the phosphate group.  Many organisms synthesize mannosidostreptomycin before the actual formation of streptomycin.
  • 19.  mannosidostreptomycin is degraded by the organism’ s own enzyme mannosidostreptomycinase to yield streptomycin.  In fermentation, the concentration of mannosidostreptomycin can reach up to 40%.  Biosynthesis of streptomycin is regulated by an inducer called FactorA.  The antibiotic is synthesized in the idiophase and this occurs only after factorA has reached a critical concentration.
  • 20.
  • 21. GENERAL PRODUCTION METHOD a. MICROBIAL STRAIN  Streptomyces griseus is used for production of streptomycin  Walksman’ s discovered the species and till now it has been using  The productivity of Streptomyces griseus has increased by over 100 fold.  Classical mutation programs are used for the improvement of the strain
  • 22. b. CULTURE MEDIUM  Glucose is the carbon source of choice, because it is precursor for streptomycin.  The preferred nitrogen source is soybean flour meal.  Minerals are automatically inclusive because of the complex nature of the medium.
  • 23. PRODUCTION  The inoculum is built up in a stepwise manner at 27°C.  The process starts with the plate culturing of lyophilized spore cultures in soy flour agar medium.  Incubation is done at 27°C for 2-3 weeks.  The spores are then transferred to shaker flask.  After growth for some time the whole is again transferred to propagator for biomass build up.  The medium is sterilized as usual.  The fermenter is inoculated at the rate of 5-10% vol/vol.The process is aerobic.
  • 24.  Inadequate supply of air (O2) leads to accumulation of lactate and pyruvate, which is undesirable.  The pH is maintained at around 7 and fermentation carried out at 27°C.  The fermentation is triphasic.Trophophase lasts for 24 hrs.  The pH increases preferential utilization of soybean meal.  Growth and concomitant accumulation of Factor A also rapid.  Idiophase lasts for 2-7 days during which streptomycin is rapidly synthesized.Glucose utilization is very rapid.  The third phase marks the cessation of antibiotic synthesis.  Cells begin to lyse, and pH rises due to NH3 liberation.  Harvesting is done before the third phase commences.  The yield is about 1200 μg/ml.
  • 25. RECOVERY  The broth (beer) is filtered in rotary vacuum filter to remove mycelia.  Water is added to the liquor in the ratio 1:1 and passed through adsorption column.  Through the same column, EDTA solution is passed to remove metal ions.  The adsorbed, pure streptomycin is eluted from the column with 2.5 N H2SO4.  Further processing entails decolorizing with carbon, antigen removal by filtration, concentration, and drying.  The final product is either sulfate- or hydrochloride salt of streptomycin.  The purity will be of the order of 98%.
  • 26.
  • 28. Introduction  Tetracyclines are a group of broad-spectrum antibiotics  They can be prepared microbiologically as well as chemically  Tetracycline has low toxicity and good oral absorption.  It is bacteriostatic and requires high dosage.  Examples ofTetracycline and organism
  • 30. Uses  This antibiotic is used in the treatment of shigellosis, salmonellosis, typhoid fever, brucellosis, etc.  It is also used in feed to eliminate parasites (and thus help weight gain in animals).  The antibiotic also finds use in the preservation of fish (the ice in which the fish is kept is treated with tetracycline).
  • 31. PRODUCTION OF TETRACYCLINE  Tetracycline can be produced chemically as well as microbiologically.  The microbial production of all tetracyclines is similar.  Chlortetracycline production, however, is comparatively simpler than the production of other tetracyclines.  In particular, production of tetracycline is very sensitive to chloride content in the medium: it leads to the production of chlortetracycline rather than the tetracycline
  • 32. FERMENTATION  For trade fermentations, UV mutants of Streptomyces aureofaciens are used.  The organism comes in the form of lyophilized spores.  The inoculum preparation requires several stages.  Starting from the spores dried on sand or lyophil vials, one or more shake flask stages may be used and then one or two inoculum tank stages.  The sporulation medium, inoculum build-up medium and the production medium have different compositions
  • 33.
  • 34.  During inoculum build-up, the organism remains in the shake-flask for 24 hours at 28°C.  The final propagator uses medium of the same composition.  About 5% inoculum is added and propagation carried out for 19-24 hours at pH 5.2-6.2.  The main fermenter receives 2-10% of inoculum from the final propagator.  The fermenter has a nominal capacity of 5000 to 15000 gallons.  Fermentation is carried out in sterilized medium (121°C for 12 hour).  The main fermentation runs for 60-65 hours at 28°C.
  • 35.  The pH is around 5.8-6.  It is a submerged fermentation requiring 0.5-2 vol/vol/min of aeration.  Agitation is carried out with mechanical agitators.  Lard is used as antifoam.  Glucose is generally not used in the main fermentation as this exerts catabolite repression.  The yield is around 15000 units per ml.